chr6-33199342-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021976.5(RXRB):c.310C>T(p.Pro104Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000711 in 1,210,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.000086 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000069 ( 0 hom. )
Consequence
RXRB
NM_021976.5 missense
NM_021976.5 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
RXRB (HGNC:10478): (retinoid X receptor beta) This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). The encoded protein forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. This gene lies within the major histocompatibility complex (MHC) class II region on chromosome 6. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.044869065).
BP6
Variant 6-33199342-G-A is Benign according to our data. Variant chr6-33199342-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3061577.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 13 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXRB | NM_021976.5 | c.310C>T | p.Pro104Ser | missense_variant | 2/10 | ENST00000374680.4 | NP_068811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXRB | ENST00000374680.4 | c.310C>T | p.Pro104Ser | missense_variant | 2/10 | 1 | NM_021976.5 | ENSP00000363812 | P4 | |
RXRB | ENST00000374685.8 | c.310C>T | p.Pro104Ser | missense_variant | 2/10 | 1 | ENSP00000363817 | A1 | ||
RXRB | ENST00000483281.5 | c.236-878C>T | intron_variant, NMD_transcript_variant | 5 | ENSP00000431369 |
Frequencies
GnomAD3 genomes AF: 0.0000859 AC: 13AN: 151398Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
13
AN:
151398
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00137 AC: 23AN: 16822Hom.: 0 AF XY: 0.00158 AC XY: 13AN XY: 8250
GnomAD3 exomes
AF:
AC:
23
AN:
16822
Hom.:
AF XY:
AC XY:
13
AN XY:
8250
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000690 AC: 73AN: 1058574Hom.: 0 Cov.: 19 AF XY: 0.0000539 AC XY: 27AN XY: 501090
GnomAD4 exome
AF:
AC:
73
AN:
1058574
Hom.:
Cov.:
19
AF XY:
AC XY:
27
AN XY:
501090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000858 AC: 13AN: 151516Hom.: 0 Cov.: 28 AF XY: 0.000135 AC XY: 10AN XY: 74008
GnomAD4 genome
AF:
AC:
13
AN:
151516
Hom.:
Cov.:
28
AF XY:
AC XY:
10
AN XY:
74008
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
9
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
RXRB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 01, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.99
.;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at